CompletedPhase 3NCT01475838
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
Studying Acquired immunodeficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gilead Sciences
- Principal Investigator
- Thai Nguyen-Cleary, MDGilead Sciences
- Intervention
- PI(drug)
- Enrollment
- 438 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2011 – 2014
Study locations (30)
- Spectrum Medical Group, Phoenix, Arizona, United States
- Pueblo Family Physicians, Phoenix, Arizona, United States
- AIDS Healthcare Foundation, Beverly Hills, California, United States
- Pacific Oaks Medical Group, Beverly Hills, California, United States
- Kaiser Permanente, Hayward, California, United States
- Kaiser Permanente, Los Angeles, California, United States
- Peter J. Ruane, M.D., Inc., Los Angeles, California, United States
- OASIS Clinic, Los Angeles, California, United States
- Anthony Mills MD Inc, Los Angeles, California, United States
- Stanford University, Palo Alto, California, United States
- University of California, Davis, Sacramento, California, United States
- Kaiser Permanente, Sacramento, California, United States
- La Playa Medical Group and Clinical Research, San Diego, California, United States
- Metropolis Medical, San Francisco, California, United States
- Kaiser Permanente San Francisco, San Francisco, California, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01475838 on ClinicalTrials.govOther trials for Acquired immunodeficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07298785Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot StudyUniversity of California, San Francisco
- ENROLLING BY INVITATIONNANCT07192419Promoting Aging and Thriving With HIVIndiana University
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07182838Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic MixHan Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- RECRUITINGNANCT07064785Video-Intervention to Inspire Treatment Adherence for Life for AdolescentsBaylor College of Medicine
- RECRUITINGNANCT06999928Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIVIndiana University
- ACTIVE NOT RECRUITINGNANCT07074899Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in PeruFred Hutchinson Cancer Center
- RECRUITINGNANCT06389565Change My Story Task Shifted Mental Health InterventionMassachusetts General Hospital
- ACTIVE NOT RECRUITINGNANCT06913660ALHIV Smartphone Game StudyEmory University